Bloomberg the Company & Products

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us


Last $0.39 USD
Change Today -0.01 / -2.50%
Volume 1.2K
BRTX On Other Exchanges
Symbol
Exchange
OTC US
As of 8:10 PM 04/27/15 All times are local (Market data is delayed by at least 15 minutes).

biorestorative therapies inc (BRTX) Snapshot

Open
$0.38
Previous Close
$0.40
Day High
$0.39
Day Low
$0.38
52 Week High
05/23/14 - $0.60
52 Week Low
06/25/14 - $0.24
Market Cap
14.5M
Average Volume 10 Days
23.8K
EPS TTM
--
Shares Outstanding
37.2M
EX-Date
--
P/E TM
--
Dividend
--
Dividend Yield
--
Current Stock Chart for BIORESTORATIVE THERAPIES INC (BRTX)

Related News

No related news articles were found.

biorestorative therapies inc (BRTX) Related Businessweek News

No Related Businessweek News Found

biorestorative therapies inc (BRTX) Details

BioRestorative Therapies, Inc., a development stage company, develops medical therapies using cell and tissue protocols, primarily involving adult stem cells that allow patients to undergo cellular-based treatments. The company’s products and medical therapies include brtxDISC, a cell therapy candidate that focuses on providing non-surgical treatment for protruding and bulging lumbar discs in patients suffering from chronic lumbar disc disease; and ThermoStem program, which focuses on the treatment of metabolic diseases, such as type 2 diabetes, obesity, hypertension, and other metabolic disorders, as well as cardiac deficiencies. It also provides Curved Needle Device, a needle system with a curved inner cannula to access difficult-to-locate regions for the delivery or removal of fluids and other substances. In addition, the company offers human and plant stem cell derived cosmetic and skin care products under the Stem Pearls brand; and develops a human adult stem cell-derived extract that enhances the production of collagen and fibronectin for combating the aging of skin. It has a research and development agreement with Rohto Pharmaceutical Co., Ltd.; and Pfizer, Inc. to provide research and development services. The company was formerly known as Stem Cell Assurance, Inc. and changed its name to BioRestorative Therapies, Inc. in August 2011. BioRestorative Therapies, Inc. was incorporated in 1997 and is based in Melville, New York.

7 Employees
Last Reported Date: 03/31/15
Founded in 1997

biorestorative therapies inc (BRTX) Top Compensated Officers

Chairman, Chief Executive Officer and Preside...
Total Annual Compensation: $360.0K
Vice President of Operations and Secretary
Total Annual Compensation: $118.0K
Vice President of Research & Development
Total Annual Compensation: $230.0K
Compensation as of Fiscal Year 2013.

biorestorative therapies inc (BRTX) Key Developments

BioRestorative Therapies, Inc. Proposes Amendments to the Certificate of Incorporation

BioRestorative Therapies, Inc. announced that the AGM to be held on May 28, 2015, it will consider for approval of the amendments to the certificate of incorporation of the company, and authorize the board of directors of the company to select and file one such amendment, to effect a reverse stock split of the company's common stock at a ratio of not less than 1-for-5 and not more than 1-for-30, with the board of directors of the company having the discretion as to whether or not the reverse stock split is to be effected, and with the exact ratio of any reverse stock split to be set at a whole number within the above range as determined by the company's board of directors in its discretion.

BioRestorative Therapies Appoints Charles S. Ryan to its Board of Directors

BioRestorative Therapies has appointed Charles S. Ryan, J.D., Ph.D. to its Board of Directors. Dr. Ryan is an experienced senior executive with an impressive background in working in the pharmaceutical and biotechnology industry. Currently, he is the Vice President, General Counsel for Cold Spring Harbor Laboratory. Prior to this position, Dr. Ryan served for over a decade at Forest Laboratories, as its Senior Vice President & Chief Intellectual Property Counsel. Dr. Ryan is filling the vacancy on the Board created by the resignation of Joseph Swiader, who stepped down due to other business commitments.

BioRestorative Therapies, Inc. Opens New Headquarters and Laboratory Facility in New York

BioRestorative Therapies, Inc. announced that the company has relocated its corporate, administrative and laboratory operations to Melville, Long Island, New York. The company had previously announced a relocation incentive program offered by New York State and Suffolk County that helped enable BRT to establish a new facility in New York for its corporate headquarters and cell biology laboratory. BRT has closed and vacated its former location in Jupiter, Florida, and has commenced operations at its new location.

 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
BRTX:US $0.39 USD -0.01

BRTX Competitors

Market data is delayed at least 15 minutes.

Company Last Change
Athersys Inc $1.23 USD -0.06
Cytori Therapeutics Inc $0.92 USD -0.07
IntelliCell BioSciences Inc $0.0002 USD 0.0001
NeoStem Inc $2.91 USD 0.00
StemCells Inc $0.60 USD -0.0076
View Industry Companies
 

Industry Analysis

BRTX

Industry Average

Valuation BRTX Industry Range
Price/Earnings NM Not Meaningful
Price/Sales 30.7x
Price/Book NM Not Meaningful
Price/Cash Flow NM Not Meaningful
TEV/Sales 21.7x
 | 

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact BIORESTORATIVE THERAPIES INC, please visit www.biorestorative.com. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.